SEC Form 4 · accession 0001140361-17-020846
OncoMed Pharmaceuticals Inc · OMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan D Root
Director
Period of report
May 11, 2017
Accepted (ET)
May 15, 2017 · 6:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001302573
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 11, 2017 | J | 55,929 | $0.00 | A | 121,020 | D | |
| Common StockF2 | May 11, 2017 | J | 1,990,783 | $0.00 | D | 0 | I | Directly owned by USVP VIII |
| Common StockF2 | May 11, 2017 | J | 19,215 | $0.00 | D | 0 | I | Directly owned by AFF VIII |
| Common StockF2 | holding | — | — | — | 18,758 | I | Directly owned by EP VIII-A | |
| Common StockF2 | holding | — | — | — | 9,509 | I | Directly owned by EP VIII-B |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Certain funds associated with the reporting person completed a distribution of shares to their limited partners (the "Distribution"). In connection with the Distribution, the reporting person received shares of common stock of the Issuer for no consideration.
- F2The reported securities are owned directly by each of U.S. Venture Partners VIII, L.P. ("USVP VIII"), USVP VIII Affiliates Fund, L.P. ("AFF VIII"), USVP Entrepreneur Partners VIII-A, L.P. ("EP VIII-A") and USVP Entrepreneur Partners VIII-B, L.P. ("EP VIII-B" and together with USVP VIII, AFF VIII and EP VIII-A, the "USVP VIII Funds"). Presidio Management Group VIII, L.L.C. ("PMG VIII") is the general partner of each of USVP VIII, AFF VIII, EP VIII-A and EP VIII-B and may be deemed to have sole voting and dispositive power over the shares held by the USVP VIII Funds. PMG VIII and each of Irwin Federman, Steven M. Krausz, David Liddle, Jonathan D. Root, Casey M. Tansey and Philip M. Young, the managing members of PMG VIII who may be deemed to share voting and dispositive power over the reported securities, disclaim beneficial ownership of the reported securities held by the USVP VIII Funds except to the extent of any pecuniary interest therein.